Value
8.6/10data confidence 67%| Component | Sub-score |
|---|---|
| P/S | 9.5 |
| Fwd P/E | 10.0 |
| PEG | 10.0 |
| Analyst target | 4.0 |
- ▸Forward P/E: 4.1x
- ▸PEG: 0.01
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
An extremely low forward P/E of 4.2x and PEG ratio near zero suggest compelling valuation, but the stock is trading above its price target with negative implied upside, revenue is declining at 23%, and quality metrics fall below the minimum bar — the cheap multiple does not yet compensate for the underlying deterioration.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Pillar | Expectation | Trend |
|---|---|---|
A forward price-to-earnings ratio of 4.2x and a PEG ratio near zero indicate the stock is pricing in substantial pessimism about future earnings power — an asymmetric setup if earnings stabilize. Valuation breakdown | Forward P/E remains below 6x while earnings estimates hold steady or rise over the next 12 months, confirming the valuation is anchored in real cash earnings rather than distorted by declining revenues. | →Stable |
| CounterCheap multiples in life insurance can reflect embedded liability risk and capital intensity that a simple P/E does not capture; with revenue declining 23%, the earnings base underpinning the low multiple may itself be eroding, making the apparent cheapness illusory. | ||
Revenue is falling at 23% on the most recent data, and growth scores at zero — signaling that the top line is contracting materially, which introduces meaningful risk to the earnings base supporting the valuation. Growth breakdown | For this pillar to be falsified, revenue growth must turn positive (above 0% year-over-year) for 2 consecutive quarters. | →Stable |
| CounterThree of the last four quarters produced earnings beats despite the revenue backdrop, suggesting cost discipline or mix shift is partially offsetting the top-line pressure — a pattern that could sustain earnings even if revenue remains soft. | ||
The stock is trading above its price target, with negative implied upside of approximately 0.3%, meaning the current price already exceeds where the analysis places near-term fair value — there is no geometric margin of safety at this entry. Warnings | For this pillar to be falsified, the price target must be revised upward such that upside exceeds 10% from the current price of $109.65. | →Stable |
| CounterThe breakout setup — golden cross, above all moving averages, rising on-balance volume — suggests price momentum could carry the stock through the current target to a higher equilibrium if positive catalysts materialize. | ||
Three of the last four quarters produced positive earnings surprises, including two beats in excess of 12%, indicating consistent execution against analyst expectations even in a difficult revenue environment. Earnings | Earnings beats continue in at least 2 of the next 3 reported quarters, with EPS surprise remaining above 0%. | →Stable |
| CounterThe most recent quarter produced a 13.6% miss — the largest magnitude move of the four periods — which, if it marks the beginning of a reversal in the beat pattern, would significantly undermine the earnings-quality case. | ||
CounterCheap multiples in life insurance can reflect embedded liability risk and capital intensity that a simple P/E does not capture; with revenue declining 23%, the earnings base underpinning the low multiple may itself be eroding, making the apparent cheapness illusory.
CounterThree of the last four quarters produced earnings beats despite the revenue backdrop, suggesting cost discipline or mix shift is partially offsetting the top-line pressure — a pattern that could sustain earnings even if revenue remains soft.
CounterThe breakout setup — golden cross, above all moving averages, rising on-balance volume — suggests price momentum could carry the stock through the current target to a higher equilibrium if positive catalysts materialize.
CounterThe most recent quarter produced a 13.6% miss — the largest magnitude move of the four periods — which, if it marks the beginning of a reversal in the beat pattern, would significantly undermine the earnings-quality case.
| Component | Sub-score |
|---|---|
| P/S | 9.5 |
| Fwd P/E | 10.0 |
| PEG | 10.0 |
| Analyst target | 4.0 |
| Component | Sub-score |
|---|---|
| ROE | 0.0 |
| ROA | 0.0 |
| Gross margin | 4.7 |
| Op margin | 10.0 |
| Net margin | 0.0 |
| Current ratio | 6.0 |
| FCF quality | 5.8 |
| Moat | 4.0 |
| Piotroski F | 6.7 |
| Component | Sub-score |
|---|---|
| Rev growth | 0.0 |
| Component | Sub-score |
|---|---|
| RSI | 5.5 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 7.0 |
| Volume | 0.0 |
| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 7.0 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.2 |
| Component | Sub-score |
|---|---|
| value rank | 3.6 |
| quality rank | 0.0 |
| growth rank | 1.3 |
| Component | Sub-score |
|---|---|
| bollinger | 3.6 |
| support resistance | 3.5 |
| 52w position | 7.8 |
| gap | 5.0 |
| Component | Sub-score |
|---|---|
| short interest | 7.2 |
| days to cover | 3.8 |
| volatility | 5.7 |
| put call | 0.4 |
| implied vol | 6.0 |
| max pain risk | 7.0 |
| beta | 5.7 |
| debt equity | 7.9 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 4.6 |
| dividend safety | 5.5 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLSetupRANGE_BOUND — RSI 58 mid-range, Bollinger mid-band
EdgeNO_EDGE — No clear edge identified
SuitabilityAGGRESSIVE — Beta 1.33>1.3
The F-path SELL output reflects an overall score of 4.7 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 8.6) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.5=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.45 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 8.6, Momentum at 6.5, and Sentiment at 5.6; the weakest are Growth at 0.0, Peer rank at 2.5, and Quality at 4.1. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.45 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifForward P/E expands above 6x while annual earnings estimates fall by more than 10%, indicating the cheap multiple is closing via earnings erosion rather than price appreciation.
Trip ifRevenue growth turns positive above 0% year-over-year for 2 consecutive quarters.
Trip ifAnalyst consensus price target rises above $121.00, restoring more than 10% upside from the current price of $109.65.
Trip ifEPS surprise falls below 0% for 2 consecutive quarters.